The vast majority of clinical CSF samples were obtained by lumbar puncture and submitted for routine genomic profiling at the Diagnostic Molecular pathology laboratory to prospectively assess for relevant genomic alterations that could inform the diagnosis, classification or treatment of a suspected solid tumor involving the CNS were identified. For all patients, clinical charts were reviewed, when available.
A. Rose
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with A.
Contact A., search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack